We believe that leveraging quantitative-based decision-making is key to transforming and enhancing the efficiency and productivity of drug development.

We operate across several inter-related domains, including model-informed drug development, pharmacometrics, clinical pharmacology, statistics, physiologically based pharmacokinetics, quantitative systems pharmacology, biopharmaceutics, and regulatory strategy.

Our clients come from, but are not limited to, the biotech and pharmaceutical industry, government, non-governmental agencies, and non-profit organizations. We maintain long-standing collaborations with universities and benefit from scientific advisors affiliated with academic centers of excellence.